Statistics
Total Visits
| Views | |
|---|---|
| Randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of Lacticaseibacillus rhamnosus CRL1505 in the prevention of upper respiratory tract infections in a healthy pediatric population | 670 |
Total Visits Per Month
| March 2026 | April 2026 | May 2026 | June 2026 | July 2026 | August 2026 | September 2026 | |
|---|---|---|---|---|---|---|---|
| Randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of Lacticaseibacillus rhamnosus CRL1505 in the prevention of upper respiratory tract infections in a healthy pediatric population | 28 | 41 | 59 | 55 | 43 | 49 | 37 |
File Visits
| Views | |
|---|---|
| Registro IRESP.PROB 2.pdf | 235 |
Top country views
| Views | |
|---|---|
| United States | 197 |
| Germany | 86 |
| Singapore | 81 |
| Hong Kong SAR China | 45 |
| Brazil | 41 |
| Ireland | 23 |
| United Kingdom | 22 |
| Vietnam | 20 |
| Spain | 17 |
| Mexico | 15 |
Top cities views
| Views | |
|---|---|
| Frankfurt am Main | 82 |
| Ashburn | 71 |
| Hong Kong | 43 |
| Council Bluffs | 24 |
| Dublin | 23 |
| San Jose | 17 |
| Singapore | 14 |
| Santafé | 10 |
| Hanoi | 9 |
| Mexico City | 8 |
